Screen, Initiate, Protect (SIP) Campaign
A campaign that encourages regular screening in CKD at risk patients and initiate guideline-directed therapy such as Jardiance to protect their kidneys early
Month 1 : CKD
Screen
CKD elevates the risk of CVD mortality when uACR>30 and/or eGFR<60
Initiate
SGLT2i is recommended as 1st line therapy in CKD according to 2024 KDIGO Guidelines
Protect
Jardiance reduced the risk of kidney disease progression or CV death by 28% across the spectrum of uACR & eGFR
